| http://dbpedia.org/ontology/abstract
|
Vernalis Research develops and applies fra … Vernalis Research develops and applies fragment and structure-based methods to drug discovery, and has generated cell active lead compounds and development candidates against biological targets in oncology, neurodegeneration, anti-infectives and inflammation.eration, anti-infectives and inflammation.
|
| http://dbpedia.org/ontology/foundingYear
|
2018
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Pharmaceutical +
, http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/Managing_Director +
, http://dbpedia.org/resource/Finance_Director +
|
| http://dbpedia.org/ontology/numberOfEmployees
|
75
|
| http://dbpedia.org/ontology/parentCompany
|
http://dbpedia.org/resource/HitGen_Inc. +
|
| http://dbpedia.org/ontology/predecessor
|
http://dbpedia.org/resource/Vernalis_plc +
|
| http://dbpedia.org/ontology/product
|
http://dbpedia.org/resource/Pharmaceuticals +
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Vernalis_Research_-_A_Ligand_Company.png?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Subsidiary +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://www.vernalis.com +
|
| http://dbpedia.org/ontology/wikiPageID
|
5744126
|
| http://dbpedia.org/ontology/wikiPageLength
|
14242
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1118319296
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Finance_Director +
, http://dbpedia.org/resource/Managing_Director +
, http://dbpedia.org/resource/Queen%27s_Award_for_Enterprise +
, http://dbpedia.org/resource/Granta_Park +
, http://dbpedia.org/resource/Cheminformatics +
, http://dbpedia.org/resource/Oncology +
, http://dbpedia.org/resource/Medicinal_chemistry +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1997 +
, http://dbpedia.org/resource/Structural_biology +
, http://dbpedia.org/resource/Assay +
, http://dbpedia.org/resource/Antiinfective +
, http://dbpedia.org/resource/Cambridge +
, http://dbpedia.org/resource/Gpcr +
, http://dbpedia.org/resource/Subsidiary +
, http://dbpedia.org/resource/Drug_metabolism +
, http://dbpedia.org/resource/Drug_development +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Asahi_Kasei +
, http://dbpedia.org/resource/Biophysics +
, http://dbpedia.org/resource/Computational_chemistry +
, http://dbpedia.org/resource/Pharmacokinetics +
, http://dbpedia.org/resource/Bcl-2 +
, http://dbpedia.org/resource/Hsp90 +
, http://dbpedia.org/resource/Pharmaceutical +
, http://dbpedia.org/resource/Protein-protein_interaction +
, http://dbpedia.org/resource/Category:1997_establishments_in_England +
, http://dbpedia.org/resource/Enzymes +
, http://dbpedia.org/resource/Novartis +
, http://dbpedia.org/resource/Pharmaceuticals +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_the_United_Kingdom +
, http://dbpedia.org/resource/A2A-adenosine_receptor +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_Kingdom +
, http://dbpedia.org/resource/HitGen_Inc. +
, http://dbpedia.org/resource/Structure-based_drug_design +
, http://dbpedia.org/resource/Servier +
, http://dbpedia.org/resource/Biological_target +
, http://dbpedia.org/resource/Lead_compound +
, http://dbpedia.org/resource/United_Kingdom +
, http://dbpedia.org/resource/Daiichi_Sankyo +
, http://dbpedia.org/resource/Drug_discovery +
, http://dbpedia.org/resource/AUY922 +
, http://dbpedia.org/resource/Molecular_modelling +
, http://dbpedia.org/resource/Vernalis_plc +
, http://dbpedia.org/resource/Lundbeck +
, http://dbpedia.org/resource/Institute_of_Cancer_Research +
, http://dbpedia.org/resource/MCL1 +
, http://dbpedia.org/resource/Neurodegeneration +
, http://dbpedia.org/resource/Ligand_Pharmaceuticals +
, http://dbpedia.org/resource/Chk1 +
, http://dbpedia.org/resource/Inflammation +
, http://dbpedia.org/resource/Synthetic_organic_chemistry +
, http://dbpedia.org/resource/FAAH +
, http://dbpedia.org/resource/Fragment-based_lead_discovery +
|
| http://dbpedia.org/property/foundation
|
2018
|
| http://dbpedia.org/property/homepage
|
https://www.vernalis.com +
|
| http://dbpedia.org/property/industry
|
Pharmaceutical and Biotechnology
|
| http://dbpedia.org/property/keyPeople
|
Clare Searle
, Mike Wood
, James Murray
|
| http://dbpedia.org/property/locationCity
|
http://dbpedia.org/resource/Cambridge +
|
| http://dbpedia.org/property/locationCountry
|
http://dbpedia.org/resource/United_Kingdom +
|
| http://dbpedia.org/property/logo
|
Vernalis Research - A Ligand Company.png
|
| http://dbpedia.org/property/name
|
Vernalis Research
|
| http://dbpedia.org/property/numEmployees
|
75
|
| http://dbpedia.org/property/owner
|
Vernalis Limited
|
| http://dbpedia.org/property/parent
|
http://dbpedia.org/resource/HitGen_Inc. +
|
| http://dbpedia.org/property/predecessor
|
http://dbpedia.org/resource/Vernalis_plc +
|
| http://dbpedia.org/property/products
|
http://dbpedia.org/resource/Pharmaceuticals +
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Subsidiary +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Use_dmy_dates +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:EngvarB +
, http://dbpedia.org/resource/Template:Pharmaceutical_industry_in_the_United_Kingdom +
, http://dbpedia.org/resource/Template:Reflist +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_the_United_Kingdom +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1997 +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_Kingdom +
, http://dbpedia.org/resource/Category:1997_establishments_in_England +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Vernalis_Research?oldid=1118319296&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Vernalis_Research_-_A_Ligand_Company.png +
|
| http://xmlns.com/foaf/0.1/homepage
|
https://www.vernalis.com +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Vernalis_Research +
|
| http://xmlns.com/foaf/0.1/name
|
Vernalis Research
|
| owl:sameAs |
http://dbpedia.org/resource/Vernalis_Research +
, https://global.dbpedia.org/id/4x7jE +
, http://arz.dbpedia.org/resource/%D8%A7%D8%A8%D8%AD%D8%A7%D8%AB_%D9%81%D9%8A%D8%B1%D9%86%D8%A7%D9%84%D9%8A%D8%B3 +
, http://www.wikidata.org/entity/Q7921942 +
|
| rdf:type |
http://dbpedia.org/ontology/Agent +
, http://www.wikidata.org/entity/Q43229 +
, http://www.wikidata.org/entity/Q4830453 +
, http://dbpedia.org/ontology/Organisation +
, http://schema.org/Organization +
, http://dbpedia.org/ontology/Company +
, http://www.wikidata.org/entity/Q24229398 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
|
| rdfs:comment |
Vernalis Research develops and applies fra … Vernalis Research develops and applies fragment and structure-based methods to drug discovery, and has generated cell active lead compounds and development candidates against biological targets in oncology, neurodegeneration, anti-infectives and inflammation.eration, anti-infectives and inflammation.
|
| rdfs:label |
Vernalis Research
|
